Cabozantinib for Patients With Recurrent or Progressive Meningioma

NCT05425004 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Meningioma

Interventions

DRUG: Cabozantinib

Sponsor

Baptist Health South Florida

Collaborators

[object Object]